The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Galantamine Is an Allosterically Potentiating Ligand of Neuronal Nicotinic but Not of Muscarinic Acetylcholine Receptors
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raskind (2000) · doi:10.1212/wnl.54.12.2261 · Cited by 870
Wilcock, G. K., Lilienfeld, S., & Gaens, E. (2000) · BMJ · doi:10.1136/bmj.321.7274.1445 · Cited by 626
Chimaeric nicotinic–serotonergic receptor combines distinct ligand binding and channel specificities
Eiselé, J.-L., Bertrand, S., Galzi, J.-L., Devillers-Thiéry, A., Changeux, J.-P., & Bertrand, D. (1993) · Nature · doi:10.1038/366479a0 · Cited by 405
Maelicke, A., Samochocki, M., Jostock, R., Fehrenbacher, A., Ludwig, J., Albuquerque, E. X., & Zerlin, M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01109-4 · Cited by 303
Self-citationSchrattenholz, A., Pereira, E. F., Roth, U., Weber, K. H., Albuquerque, E. X., & Maelicke, A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08675-4 · Cited by 226
Self-citationMaelicke, A., & Albuquerque, E. X. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00093-5 · Cited by 222
Self-citationMartin‐Ruiz, C. M., Court, J. A., Molnar, E., Lee, M., Gotti, C., Mamalaki, A., Tsouloufis, T., Tzartos, S., Ballard, C., Perry, R. H., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731635.x · Cited by 195
Galantamine: Effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning
Woodruff-Pak, D. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031584398 · Cited by 188
Rivastigmine: A Review of its Use in Alzheimer??s Disease
Spencer, C. M., & Noble, S. (1998) · Drugs & Aging · doi:10.2165/00002512-199813050-00005 · Cited by 187
Burghaus, L., Schütz, U., Krempel, U., de Vos, R. A. I., Jansen Steur, E. N. H., Wevers, A., Lindstrom, J., & Schröder, H. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00031-0 · Cited by 178
Cited by
Mammalian nicotinic acetylcholine receptors: from structure to function
Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., & Rogers, S. W. (2009) · Physiological Reviews · doi:10.1152/physrev.00015.2008 · Cited by 1,724
Self-citationMillan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Jensen, A. A., Frølund, B., Liljefors, T., & Krogsgaard-Larsen, P. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040219e · Cited by 542
Demystifying traditional herbal medicine with modern approach
Li, F.-S., & Weng, J.-K. (2017) · Nature Plants · doi:10.1038/nplants.2017.109 · Cited by 498
Cys-loop receptors: new twists and turns
LESTER, H. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.002 · Cited by 438
Amaryllidaceae and Sceletium alkaloids
Jin, Z. (2013) · Natural Product Reports · doi:10.1039/c3np70005d · Cited by 409
Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders
Zhang, Z.-J. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.04.014 · Cited by 344
Free Energy, Precision and Learning: The Role of Cholinergic Neuromodulation
Moran, R. J., Campo, P., Symmonds, M., Stephan, K. E., Dolan, R. J., & Friston, K. J. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4255-12.2013 · Cited by 312
Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine
Zemek, F., Drtinova, L., Nepovimova, E., Sepsova, V., Korabecny, J., Klimes, J., & Kuca, K. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.914168 · Cited by 299
Synthesis and Pharmacology of Galantamine
Marco-Contelles, J., do Carmo Carreiras, M., Rodríguez, C., Villarroya, M., & García, A. G. (2006) · Chemical Reviews · doi:10.1021/cr040415t · Cited by 293
Nicotine acts as a pharmacological chaperone to up-regulate human α4β2 acetylcholine receptors
Kuryatov, A., Luo, J., Cooper, J., & Lindstrom, J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012419 · Cited by 275
Halvard Grønlien, J., Håkerud, M., Ween, H., Thorin-Hagene, K., Briggs, C. A., Gopalakrishnan, M., & Malysz, J. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.035410 · Cited by 271
Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review
Minati, L., Edginton, T., Grazia Bruzzone, M., & Giaccone, G. (2009) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317508328602 · Cited by 268
Nerve Agents: What They Are, How They Work, How to Counter Them
Costanzi, S., Machado, J.-H., & Mitchell, M. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00148 · Cited by 253
Roles of Accessory Subunits in α4β2* Nicotinic Receptors
Kuryatov, A., Onksen, J., & Lindstrom, J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046789 · Cited by 195
Takata, K., Kitamura, Y., Saeki, M., Terada, M., Kagitani, S., Kitamura, R., Fujikawa, Y., Maelicke, A., Tomimoto, H., Taniguchi, T., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.142356 · Cited by 176
Self-citationKuryatov, A., Berrettini, W., & Lindstrom, J. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.066357 · Cited by 171
Neuroprotective effects of huperzine A: New therapeutic targets for neurodegenerative disease
Zhang, H. Y., & Tang, X. C. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.10.004 · Cited by 174
Galantamine for the treatment of cognitive impairments in people with schizophrenia
Buchanan, R. W., Conley, R. R., Dickinson, D., Ball, M. P., Feldman, S., Gold, J. M., & McMahon, R. P. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07050724 · Cited by 170
Simoni, E., Daniele, S., Bottegoni, G., Pizzirani, D., Trincavelli, M. L., Goldoni, L., Tarozzo, G., Reggiani, A., Martini, C., Piomelli, D., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3009458 · Cited by 163
Multitarget drugs of plants origin acting on Alzheimer’s disease
Russo, P., Frustaci, A., Del Bufalo, A., Fini, M., & Cesario, A. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320130008 · Cited by 88
BACE1 molecular docking and anti-Alzheimer’s disease activities of ginsenosides
Choi, R. J., Roy, A., Jung, H. J., Ali, M. Y., Min, B.-S., Park, C. H., Yokozawa, T., Fan, T.-P., Choi, J. S., & Jung, H. A. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.06.013 · Cited by 77
Galantamine potentiates the neuroprotective effect of memantine against NMDA‐induced excitotoxicity
Lopes, J. P., Tarozzo, G., Reggiani, A., Piomelli, D., & Cavalli, A. (2013) · Brain and Behavior · doi:10.1002/brb3.118 · Cited by 64
Model-based prediction of muscarinic receptor function from auditory mismatch negativity responses
Schöbi, D., Homberg, F., Frässle, S., Endepols, H., Moran, R. J., Friston, K. J., Tittgemeyer, M., Heinzle, J., & Stephan, K. E. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118096 · Cited by 25
Natural Products from Plants and Algae for Treatment of Alzheimer’s Disease: A Review
Klose, J., Griehl, C., Roßner, S., & Schilling, S. (2022) · Biomolecules · doi:10.3390/biom12050694 · Cited by 23
Metadata
- Authors
- Samochocki, M., Höffle, A., Fehrenbacher, A., Jostock, R., Ludwig, J., Christner, C., Radina, M., Zerlin, M., Ullmer, C., Pereira, E. F. R., Lübbert, H., Albuquerque, E. X., & Maelicke, A.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 305
- Issue
- 3
- Pages
- 1024-1036
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2155997108
- Cited by
- 345
- References
- 36
- FWCI
- 7.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.